<h4>Objective</h4>Both pulsatile gonadotropin-releasing hormone (GnRH) and combined gonadotropin therapy are effective to induce spermatogenesis in men with congenital hypogonadotropic hypogonadism (CHH). This evidence concerns the gene GNRH1 and congenital hypogonadotropic hypogonadism.